Quanterix Faces Significant Supply Chain Risk From Single-Source Instrument Manufacturers

Quanterix (QTRX) has disclosed a new risk, in the Supply Chain category.

Quanterix remains exposed to concentration risk because it depends on single-source contract manufacturers, including STRATEC, Paramit and Columbia Tech, for production of its key Simoa HD-X, SR-X, PhenoCycler and PhenoImager instruments. Any failure, delay or quantity shortfall at these manufacturers, or at their own limited or sole component suppliers, could materially disrupt instrument supply and adversely affect Quanterix’s business, financial condition, operating results and reputation.

The average QTRX stock price target is $7.50, implying 27.77% upside potential.

To learn more about Quanterix’s risk factors, click here.